Department of Psychiatry, Hamad Medical Corporation, Doha, Qatar.
Weill Cornell Medical College, Medical Education, Doha, Qatar.
PLoS One. 2020 Nov 9;15(11):e0241986. doi: 10.1371/journal.pone.0241986. eCollection 2020.
Even though all guidelines recommend generally against antipsychotic polypharmacy, antipsychotic polypharmacy appears to be a very common practice across the globe. This study aimed to examine the prescription patterns of antipsychotics in Qatar, in comparison with the international guidelines, and to scrutinize the sociodemographic and clinical features associated with antipsychotic polypharmacy.
All the medical records of all the inpatients and outpatients treated by antipsychotics at the Department of Psychiatry-Hamad Medical Corporation (HMC) in Doha, Qatar (between October 2012 and April 2014) were retrospectively analyzed. We retrieved the available sociodemographic data, psychiatric features, and details on the medication history.
Our sample consisted of 537 individuals on antipsychotics (2/3 were male; mean age 33.8±10.2 years), prescribed for a psychotic disorder in 57%, a mood disorder in 9.3%, and various other diagnoses in 33.7%. About 55.9% received one antipsychotic, 29.6% received two antipsychotics, and 14.5% received more than two antipsychotics. Polypharmacy was associated with younger age (p = 0.025), being single (p<0.001), the diagnosis of a psychotic disorder (p<0.001), and previous admissions to psychiatry (p<0.001).
Antipsychotic polypharmacy appears to be quite common in Qatar, as it is the case in many other countries, in contrast with most international recommendations. Studies are needed to explore the reasons behind this disparity.
尽管所有指南均建议一般避免使用抗精神病药联合用药,但抗精神病药联合用药似乎在全球范围内非常普遍。本研究旨在检查卡塔尔的抗精神病药处方模式,与国际指南进行比较,并仔细研究与抗精神病药联合用药相关的社会人口学和临床特征。
回顾性分析了 2012 年 10 月至 2014 年 4 月在卡塔尔多哈的哈马德医疗公司(Hamad Medical Corporation)精神病学部接受抗精神病药治疗的所有住院和门诊患者的所有病历。我们检索了可用的社会人口学数据、精神科特征以及药物治疗史的详细信息。
我们的样本包括 537 名接受抗精神病药治疗的个体(2/3 为男性;平均年龄 33.8±10.2 岁),其中 57%被诊断为精神病性障碍,9.3%为心境障碍,33.7%为其他各种诊断。约 55.9%的患者接受一种抗精神病药,29.6%的患者接受两种抗精神病药,14.5%的患者接受两种以上的抗精神病药。联合用药与年龄较小(p = 0.025)、单身(p<0.001)、精神病性障碍诊断(p<0.001)和先前精神病住院治疗(p<0.001)有关。
抗精神病药联合用药在卡塔尔似乎相当普遍,与许多其他国家一样,与大多数国际建议相反。需要进行研究以探讨这种差异背后的原因。